A Dose-finding Study of CC-90009 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-risk Myelodysplastic Syndromes

Local Institution - 603, Badalona

Institut Paoli Calmettes, Marseille

Local Institution - 604, Madrid

Local Institution - 605, Pamplona

Local Institution - 502, Toulouse

Local Institution - 601, Salamanca

Local Institution - 600, Valencia

Local Institution - 505, Lillie Cedex

Local Institution - 102, Chicago

Local Institution - 101, St Louis

Hopital Lyon Sud, Pierre-Bénite

Stanford Cancer Center, Stanford

Local Institution - 105, New Haven

Local Institution - 103, Boston

Local Institution - 104, Hackensack

Local Institution - 201, Toronto

Local Institution - 700, Bergen

Local Institution - 701, Oslo

Local Institution - 602, Barcelona

Local Institution - 301, Oxford